micromolar exposures of estrogen ( 17 beta-estradiol ) , antiestrogen ( tamoxifen ) , antiandrogen ( dehydroxyflutamide ) , progestins ( progesterone , r5020 , medroxyprogesterone acetate ) , and inhibitors of steroid-metabolizing enzymes ( 17 beta-n , n-diethylcarbamyl-4-methyl-4-aza-5 alpha-androstan-3-one , danazol ) impair growth of these pancreatic tumors to varying degrees , and with little relationship to estrogen receptor content .
C0039286
tamoxifen
C0030297
of